Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...

XORTX’s board of directors accepted the resignation of the Former Auditor, as of January 16, 2025 and appointed the Successor Auditor as the new auditor of the Company effective January 16, 2025, and ...

Lifecore’s board of directors has approved that holders of record of Lifecore’s Common Stock and Convertible Preferred Stock as of the close of business on February 18, 2025 (the “Record Date”), will ...

Following the successful launch of its GLP Compass (™), Digbi Health continues to innovate by expanding its obesity test capabilities in 2025. These enhancements guide care providers and benefit ...

Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to ...

Legend Memory Care brings award-winning, results-oriented expert care, which has been shown to improve cognition, memory function and socialization. “We're very proud to expand the Legend mission to ...

The Super Air Smart ICU is available now in the United States and will be on display at the 2025 Veterinary Meeting & Expo (VMX), Booth 913, Jan. 25 – 29 in Orlando, FL. For more information, visit ...

Enthea is proud to announce that it will be presenting at the upcoming Sequire Investor Summit 2025. The 2025 Edition of the Sequire Investor Summit is scheduled for January 21st-23rd, 2025, at ...

Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin ...

Louvain-La-Neuve, Belgique, le 17 janvier 2025 – IBA (Ion Beam Applications S.A., EURONEXT), leader mondial de la technologie des accélérateurs de particules et principal fournisseur de solutions de p ...

Developed by a collaborative team of health professionals, nutritionists, and men’s wellness advocates, ProstaVive unites the latest 2023 scientific findings with time-tested botanical knowledge. This ...

General Manager and CEO of Junshi Biosciences, Dr. Jianjun ZOU, said, “Toripalimab has made significant strides in its internationalization. As of today, toripalimab has been approved in 35 countries ...